nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—migraine—Prednisone—chronic obstructive pulmonary disease	0.43	1	CpDpCtD
Eletriptan—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0499	0.126	CbGbCtD
Eletriptan—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0499	0.126	CbGbCtD
Eletriptan—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0378	0.0955	CbGbCtD
Eletriptan—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0323	0.0816	CbGbCtD
Eletriptan—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0222	0.0561	CbGbCtD
Eletriptan—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0206	0.0521	CbGbCtD
Eletriptan—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0206	0.0521	CbGbCtD
Eletriptan—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0171	0.0433	CbGbCtD
Eletriptan—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0171	0.0433	CbGbCtD
Eletriptan—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0157	0.0396	CbGbCtD
Eletriptan—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0157	0.0396	CbGbCtD
Eletriptan—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.014	0.0353	CbGbCtD
Eletriptan—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0132	0.0333	CbGbCtD
Eletriptan—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.013	0.0329	CbGbCtD
Eletriptan—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00889	0.0225	CbGbCtD
Eletriptan—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00866	0.0219	CbGbCtD
Eletriptan—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00848	0.0214	CbGbCtD
Eletriptan—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00756	0.0191	CbGbCtD
Eletriptan—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0074	0.0187	CbGbCtD
Eletriptan—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00699	0.0177	CbGbCtD
Eletriptan—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00443	0.0112	CbGbCtD
Eletriptan—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00419	0.0106	CbGbCtD
Eletriptan—Zolmitriptan—CYP1A2—chronic obstructive pulmonary disease	0.000663	0.379	CrCbGaD
Eletriptan—Almotriptan—CYP1A2—chronic obstructive pulmonary disease	0.000502	0.287	CrCbGaD
Eletriptan—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.00022	0.126	CrCbGaD
Eletriptan—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.112	CrCbGaD
Eletriptan—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000166	0.0949	CrCbGaD
Eletriptan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00108	CcSEcCtD
Eletriptan—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00108	CcSEcCtD
Eletriptan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00107	CcSEcCtD
Eletriptan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00107	CcSEcCtD
Eletriptan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00107	CcSEcCtD
Eletriptan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Eletriptan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Eletriptan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00013	0.00106	CcSEcCtD
Eletriptan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Eletriptan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Eletriptan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Eletriptan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Eletriptan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00105	CcSEcCtD
Eletriptan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00105	CcSEcCtD
Eletriptan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00105	CcSEcCtD
Eletriptan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Eletriptan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Eletriptan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Eletriptan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00104	CcSEcCtD
Eletriptan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000127	0.00104	CcSEcCtD
Eletriptan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00103	CcSEcCtD
Eletriptan—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00103	CcSEcCtD
Eletriptan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00103	CcSEcCtD
Eletriptan—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00103	CcSEcCtD
Eletriptan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00102	CcSEcCtD
Eletriptan—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00102	CcSEcCtD
Eletriptan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00101	CcSEcCtD
Eletriptan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Eletriptan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000123	0.001	CcSEcCtD
Eletriptan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.000997	CcSEcCtD
Eletriptan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000997	CcSEcCtD
Eletriptan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000994	CcSEcCtD
Eletriptan—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000992	CcSEcCtD
Eletriptan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000989	CcSEcCtD
Eletriptan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000984	CcSEcCtD
Eletriptan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.00098	CcSEcCtD
Eletriptan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000979	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000978	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000978	CcSEcCtD
Eletriptan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000119	0.00097	CcSEcCtD
Eletriptan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.00097	CcSEcCtD
Eletriptan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000118	0.000966	CcSEcCtD
Eletriptan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.000965	CcSEcCtD
Eletriptan—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000118	0.00096	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000958	CcSEcCtD
Eletriptan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000957	CcSEcCtD
Eletriptan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000957	CcSEcCtD
Eletriptan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000954	CcSEcCtD
Eletriptan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000954	CcSEcCtD
Eletriptan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000951	CcSEcCtD
Eletriptan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000947	CcSEcCtD
Eletriptan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000944	CcSEcCtD
Eletriptan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000944	CcSEcCtD
Eletriptan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000116	0.000944	CcSEcCtD
Eletriptan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.000941	CcSEcCtD
Eletriptan—Injury—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000935	CcSEcCtD
Eletriptan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000934	CcSEcCtD
Eletriptan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.000932	CcSEcCtD
Eletriptan—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00093	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000926	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000926	CcSEcCtD
Eletriptan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000113	0.000925	CcSEcCtD
Eletriptan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000925	CcSEcCtD
Eletriptan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000925	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000923	CcSEcCtD
Eletriptan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Eletriptan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Eletriptan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Eletriptan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000918	CcSEcCtD
Eletriptan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000916	CcSEcCtD
Eletriptan—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000914	CcSEcCtD
Eletriptan—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000914	CcSEcCtD
Eletriptan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00091	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000907	CcSEcCtD
Eletriptan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000906	CcSEcCtD
Eletriptan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000903	CcSEcCtD
Eletriptan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000901	CcSEcCtD
Eletriptan—Pain—Montelukast—chronic obstructive pulmonary disease	0.00011	0.000899	CcSEcCtD
Eletriptan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000898	CcSEcCtD
Eletriptan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00011	0.000896	CcSEcCtD
Eletriptan—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000893	CcSEcCtD
Eletriptan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000893	CcSEcCtD
Eletriptan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000892	CcSEcCtD
Eletriptan—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000891	CcSEcCtD
Eletriptan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000889	CcSEcCtD
Eletriptan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000888	CcSEcCtD
Eletriptan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000886	CcSEcCtD
Eletriptan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000884	CcSEcCtD
Eletriptan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000884	CcSEcCtD
Eletriptan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000108	0.000883	CcSEcCtD
Eletriptan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000881	CcSEcCtD
Eletriptan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.000879	CcSEcCtD
Eletriptan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000877	CcSEcCtD
Eletriptan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000877	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000875	CcSEcCtD
Eletriptan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000873	CcSEcCtD
Eletriptan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000866	CcSEcCtD
Eletriptan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000866	CcSEcCtD
Eletriptan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000859	CcSEcCtD
Eletriptan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000859	CcSEcCtD
Eletriptan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000852	CcSEcCtD
Eletriptan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000852	CcSEcCtD
Eletriptan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000848	CcSEcCtD
Eletriptan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000848	CcSEcCtD
Eletriptan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000848	CcSEcCtD
Eletriptan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000848	CcSEcCtD
Eletriptan—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000846	CcSEcCtD
Eletriptan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.000845	CcSEcCtD
Eletriptan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.000838	CcSEcCtD
Eletriptan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.000838	CcSEcCtD
Eletriptan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000837	CcSEcCtD
Eletriptan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000835	CcSEcCtD
Eletriptan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000835	CcSEcCtD
Eletriptan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000102	0.000833	CcSEcCtD
Eletriptan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.000833	CcSEcCtD
Eletriptan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000831	CcSEcCtD
Eletriptan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000102	0.000831	CcSEcCtD
Eletriptan—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000829	CcSEcCtD
Eletriptan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000828	CcSEcCtD
Eletriptan—Mood swings—Prednisone—chronic obstructive pulmonary disease	9.98e-05	0.000814	CcSEcCtD
Eletriptan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.87e-05	0.000805	CcSEcCtD
Eletriptan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	9.82e-05	0.000801	CcSEcCtD
Eletriptan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	9.82e-05	0.000801	CcSEcCtD
Eletriptan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.7e-05	0.000791	CcSEcCtD
Eletriptan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.7e-05	0.000791	CcSEcCtD
Eletriptan—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.69e-05	0.00079	CcSEcCtD
Eletriptan—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.67e-05	0.000788	CcSEcCtD
Eletriptan—Dry skin—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000787	CcSEcCtD
Eletriptan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	9.5e-05	0.000774	CcSEcCtD
Eletriptan—Asthenia—Formoterol—chronic obstructive pulmonary disease	9.44e-05	0.00077	CcSEcCtD
Eletriptan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	9.44e-05	0.00077	CcSEcCtD
Eletriptan—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.31e-05	0.000759	CcSEcCtD
Eletriptan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.31e-05	0.000759	CcSEcCtD
Eletriptan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	9.29e-05	0.000758	CcSEcCtD
Eletriptan—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.25e-05	0.000754	CcSEcCtD
Eletriptan—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000748	CcSEcCtD
Eletriptan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.15e-05	0.000746	CcSEcCtD
Eletriptan—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.12e-05	0.000744	CcSEcCtD
Eletriptan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9e-05	0.000734	CcSEcCtD
Eletriptan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9e-05	0.000734	CcSEcCtD
Eletriptan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.96e-05	0.000731	CcSEcCtD
Eletriptan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.92e-05	0.000727	CcSEcCtD
Eletriptan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.82e-05	0.000719	CcSEcCtD
Eletriptan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.79e-05	0.000717	CcSEcCtD
Eletriptan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.7e-05	0.00071	CcSEcCtD
Eletriptan—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.7e-05	0.00071	CcSEcCtD
Eletriptan—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.52e-05	0.000695	CcSEcCtD
Eletriptan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	8.5e-05	0.000693	CcSEcCtD
Eletriptan—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	8.39e-05	0.000684	CcSEcCtD
Eletriptan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.37e-05	0.000682	CcSEcCtD
Eletriptan—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.37e-05	0.000682	CcSEcCtD
Eletriptan—Rash—Arformoterol—chronic obstructive pulmonary disease	8.3e-05	0.000677	CcSEcCtD
Eletriptan—Rash—Formoterol—chronic obstructive pulmonary disease	8.3e-05	0.000677	CcSEcCtD
Eletriptan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.29e-05	0.000676	CcSEcCtD
Eletriptan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.29e-05	0.000676	CcSEcCtD
Eletriptan—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000676	CcSEcCtD
Eletriptan—Headache—Formoterol—chronic obstructive pulmonary disease	8.24e-05	0.000672	CcSEcCtD
Eletriptan—Headache—Arformoterol—chronic obstructive pulmonary disease	8.24e-05	0.000672	CcSEcCtD
Eletriptan—Weight decreased—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000672	CcSEcCtD
Eletriptan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.22e-05	0.00067	CcSEcCtD
Eletriptan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.00067	CcSEcCtD
Eletriptan—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.2e-05	0.000668	CcSEcCtD
Eletriptan—Rash—Montelukast—chronic obstructive pulmonary disease	8.13e-05	0.000663	CcSEcCtD
Eletriptan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.12e-05	0.000662	CcSEcCtD
Eletriptan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.1e-05	0.000661	CcSEcCtD
Eletriptan—Headache—Montelukast—chronic obstructive pulmonary disease	8.07e-05	0.000658	CcSEcCtD
Eletriptan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	8e-05	0.000653	CcSEcCtD
Eletriptan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.98e-05	0.000651	CcSEcCtD
Eletriptan—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000649	CcSEcCtD
Eletriptan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.96e-05	0.000649	CcSEcCtD
Eletriptan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.9e-05	0.000644	CcSEcCtD
Eletriptan—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.87e-05	0.000642	CcSEcCtD
Eletriptan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.85e-05	0.00064	CcSEcCtD
Eletriptan—Rash—Salbutamol—chronic obstructive pulmonary disease	7.83e-05	0.000639	CcSEcCtD
Eletriptan—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.83e-05	0.000639	CcSEcCtD
Eletriptan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.83e-05	0.000638	CcSEcCtD
Eletriptan—Nausea—Formoterol—chronic obstructive pulmonary disease	7.82e-05	0.000637	CcSEcCtD
Eletriptan—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.82e-05	0.000637	CcSEcCtD
Eletriptan—Headache—Salbutamol—chronic obstructive pulmonary disease	7.78e-05	0.000635	CcSEcCtD
Eletriptan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.68e-05	0.000626	CcSEcCtD
Eletriptan—Nausea—Montelukast—chronic obstructive pulmonary disease	7.66e-05	0.000624	CcSEcCtD
Eletriptan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000617	CcSEcCtD
Eletriptan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.54e-05	0.000615	CcSEcCtD
Eletriptan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.000605	CcSEcCtD
Eletriptan—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.38e-05	0.000602	CcSEcCtD
Eletriptan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.35e-05	0.000599	CcSEcCtD
Eletriptan—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000591	CcSEcCtD
Eletriptan—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.13e-05	0.000581	CcSEcCtD
Eletriptan—Shock—Prednisolone—chronic obstructive pulmonary disease	7.01e-05	0.000572	CcSEcCtD
Eletriptan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.96e-05	0.000567	CcSEcCtD
Eletriptan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.89e-05	0.000562	CcSEcCtD
Eletriptan—Flushing—Prednisone—chronic obstructive pulmonary disease	6.77e-05	0.000552	CcSEcCtD
Eletriptan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.58e-05	0.000537	CcSEcCtD
Eletriptan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.51e-05	0.000531	CcSEcCtD
Eletriptan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.45e-05	0.000526	CcSEcCtD
Eletriptan—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000525	CcSEcCtD
Eletriptan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.4e-05	0.000522	CcSEcCtD
Eletriptan—Pain—Prednisolone—chronic obstructive pulmonary disease	6.09e-05	0.000497	CcSEcCtD
Eletriptan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.89e-05	0.00048	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000479	CcSEcCtD
Eletriptan—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.000478	CcSEcCtD
Eletriptan—Agitation—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000475	CcSEcCtD
Eletriptan—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.8e-05	0.000473	CcSEcCtD
Eletriptan—Malaise—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.000467	CcSEcCtD
Eletriptan—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.7e-05	0.000465	CcSEcCtD
Eletriptan—Syncope—Prednisone—chronic obstructive pulmonary disease	5.69e-05	0.000464	CcSEcCtD
Eletriptan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.66e-05	0.000462	CcSEcCtD
Eletriptan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.000455	CcSEcCtD
Eletriptan—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000448	CcSEcCtD
Eletriptan—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.000447	CcSEcCtD
Eletriptan—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.00044	CcSEcCtD
Eletriptan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.00044	CcSEcCtD
Eletriptan—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000439	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000437	CcSEcCtD
Eletriptan—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.000435	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.25e-05	0.000428	CcSEcCtD
Eletriptan—Oedema—Prednisone—chronic obstructive pulmonary disease	5.18e-05	0.000422	CcSEcCtD
Eletriptan—Shock—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.000415	CcSEcCtD
Eletriptan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.000414	CcSEcCtD
Eletriptan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.05e-05	0.000412	CcSEcCtD
Eletriptan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.00041	CcSEcCtD
Eletriptan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000408	CcSEcCtD
Eletriptan—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.000403	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.72e-05	0.000385	CcSEcCtD
Eletriptan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.71e-05	0.000384	CcSEcCtD
Eletriptan—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000382	CcSEcCtD
Eletriptan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.65e-05	0.000379	CcSEcCtD
Eletriptan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.000372	CcSEcCtD
Eletriptan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.5e-05	0.000367	CcSEcCtD
Eletriptan—Rash—Prednisolone—chronic obstructive pulmonary disease	4.49e-05	0.000366	CcSEcCtD
Eletriptan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.49e-05	0.000366	CcSEcCtD
Eletriptan—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.46e-05	0.000364	CcSEcCtD
Eletriptan—Headache—Prednisolone—chronic obstructive pulmonary disease	4.46e-05	0.000364	CcSEcCtD
Eletriptan—Constipation—Prednisone—chronic obstructive pulmonary disease	4.43e-05	0.000361	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000348	CcSEcCtD
Eletriptan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.23e-05	0.000345	CcSEcCtD
Eletriptan—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.23e-05	0.000345	CcSEcCtD
Eletriptan—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.11e-05	0.000335	CcSEcCtD
Eletriptan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.09e-05	0.000334	CcSEcCtD
Eletriptan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.09e-05	0.000334	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.82e-05	0.000311	CcSEcCtD
Eletriptan—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.72e-05	0.000303	CcSEcCtD
Eletriptan—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.66e-05	0.000299	CcSEcCtD
Eletriptan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.54e-05	0.000289	CcSEcCtD
Eletriptan—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.42e-05	0.000279	CcSEcCtD
Eletriptan—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.29e-05	0.000268	CcSEcCtD
Eletriptan—Rash—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000266	CcSEcCtD
Eletriptan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000266	CcSEcCtD
Eletriptan—Headache—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.000265	CcSEcCtD
Eletriptan—Nausea—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000251	CcSEcCtD
Eletriptan—HTR1F—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.68e-05	0.000336	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.67e-05	0.000334	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.66e-05	0.000333	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.66e-05	0.000332	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.66e-05	0.000332	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.6e-05	0.00032	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.59e-05	0.000318	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.58e-05	0.000317	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.58e-05	0.000316	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.57e-05	0.000315	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.55e-05	0.000309	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.55e-05	0.000309	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.53e-05	0.000307	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000305	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000304	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.51e-05	0.000303	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.51e-05	0.000302	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.51e-05	0.000301	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.5e-05	0.000301	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.48e-05	0.000297	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.47e-05	0.000294	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.46e-05	0.000292	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.45e-05	0.000291	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.44e-05	0.000288	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.43e-05	0.000286	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000285	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.000285	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.42e-05	0.000284	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.000284	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.41e-05	0.000282	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.000282	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.4e-05	0.000281	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.4e-05	0.00028	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.4e-05	0.00028	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.00028	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.39e-05	0.000278	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.38e-05	0.000277	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.000275	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.37e-05	0.000274	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.36e-05	0.000273	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.36e-05	0.000272	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.36e-05	0.000271	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.35e-05	0.00027	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.35e-05	0.000269	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.33e-05	0.000267	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000263	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.3e-05	0.00026	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.3e-05	0.000259	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.29e-05	0.000259	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.29e-05	0.000257	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.29e-05	0.000257	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.28e-05	0.000256	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.28e-05	0.000256	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.27e-05	0.000255	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.27e-05	0.000253	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.22e-05	0.000244	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.22e-05	0.000243	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.2e-05	0.00024	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.19e-05	0.000239	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.19e-05	0.000238	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.000237	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.000236	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000234	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.17e-05	0.000234	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.12e-05	0.000224	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.12e-05	0.000224	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000223	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.11e-05	0.000223	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.1e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.1e-05	0.00022	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.08e-05	0.000216	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.07e-05	0.000215	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.07e-05	0.000215	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.07e-05	0.000213	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.06e-05	0.000213	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.00021	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.05e-05	0.00021	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.05e-05	0.000209	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.04e-05	0.000209	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.04e-05	0.000208	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000203	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.000203	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1e-05	0.000201	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.88e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.88e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.82e-06	0.000196	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.8e-06	0.000196	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.75e-06	0.000195	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.75e-06	0.000195	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.74e-06	0.000195	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.69e-06	0.000194	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.64e-06	0.000193	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.58e-06	0.000192	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.55e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.49e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.39e-06	0.000188	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.34e-06	0.000187	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.32e-06	0.000187	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.3e-06	0.000186	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.22e-06	0.000184	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.21e-06	0.000184	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.13e-06	0.000183	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.08e-06	0.000182	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.04e-06	0.000181	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.01e-06	0.00018	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.97e-06	0.000179	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.91e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.9e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.72e-06	0.000175	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.67e-06	0.000173	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.6e-06	0.000172	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.58e-06	0.000172	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.58e-06	0.000172	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.57e-06	0.000171	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.5e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.49e-06	0.00017	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.41e-06	0.000168	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.22e-06	0.000164	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.15e-06	0.000163	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.14e-06	0.000163	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8.12e-06	0.000163	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.08e-06	0.000162	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.02e-06	0.00016	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.01e-06	0.00016	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.97e-06	0.00016	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.95e-06	0.000159	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.93e-06	0.000159	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.69e-06	0.000154	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.57e-06	0.000152	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.56e-06	0.000151	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.49e-06	0.00015	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.47e-06	0.000149	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.41e-06	0.000148	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.4e-06	0.000148	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.32e-06	0.000146	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.27e-06	0.000146	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.23e-06	0.000145	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.23e-06	0.000145	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.17e-06	0.000144	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.13e-06	0.000143	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.03e-06	0.000141	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.98e-06	0.00014	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.95e-06	0.000139	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.9e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.9e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.85e-06	0.000137	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.83e-06	0.000137	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.82e-06	0.000136	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.8e-06	0.000136	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.76e-06	0.000135	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.71e-06	0.000134	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.66e-06	0.000133	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.66e-06	0.000133	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.58e-06	0.000132	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.56e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.54e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.49e-06	0.00013	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.47e-06	0.000129	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.36e-06	0.000127	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.33e-06	0.000127	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.28e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.26e-06	0.000125	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.23e-06	0.000125	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.21e-06	0.000124	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.97e-06	0.00012	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	5.85e-06	0.000117	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.8e-06	0.000116	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.76e-06	0.000115	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.69e-06	0.000114	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.64e-06	0.000113	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.62e-06	0.000112	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.59e-06	0.000112	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.56e-06	0.000111	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	5.53e-06	0.000111	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.53e-06	0.000111	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.51e-06	0.00011	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.48e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.48e-06	0.00011	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.36e-06	0.000107	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.32e-06	0.000106	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.3e-06	0.000106	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.29e-06	0.000106	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.24e-06	0.000105	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.24e-06	0.000105	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.23e-06	0.000105	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.21e-06	0.000104	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.21e-06	0.000104	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.19e-06	0.000104	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.17e-06	0.000103	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.12e-06	0.000102	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.11e-06	0.000102	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.1e-06	0.000102	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.07e-06	0.000102	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.06e-06	0.000101	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.04e-06	0.000101	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.96e-06	9.93e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.94e-06	9.89e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.88e-06	9.77e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.84e-06	9.69e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.84e-06	9.69e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.81e-06	9.63e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.79e-06	9.59e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.77e-06	9.55e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.77e-06	9.55e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.71e-06	9.42e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.68e-06	9.36e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.58e-06	9.17e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.56e-06	9.13e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.52e-06	9.05e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.46e-06	8.92e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.32e-06	8.65e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.3e-06	8.61e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.3e-06	8.6e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-06	8.59e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.24e-06	8.48e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.21e-06	8.43e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.2e-06	8.41e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.12e-06	8.25e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.11e-06	8.22e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.09e-06	8.18e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.95e-06	7.9e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.89e-06	7.78e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.87e-06	7.75e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.56e-06	7.12e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.54e-06	7.07e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.49e-06	6.98e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.46e-06	6.93e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.42e-06	6.85e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.38e-06	6.76e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.37e-06	6.75e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.29e-06	6.59e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.26e-06	6.52e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.25e-06	6.51e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.24e-06	6.48e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.23e-06	6.46e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.2e-06	6.41e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.17e-06	6.34e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.15e-06	6.3e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.15e-06	6.3e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.14e-06	6.29e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	6.21e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.07e-06	6.15e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.98e-06	5.97e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.98e-06	5.96e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.97e-06	5.94e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.94e-06	5.89e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.64e-06	5.28e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.41e-06	4.83e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.03e-06	4.06e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.94e-06	3.88e-05	CbGpPWpGaD
